trending Market Intelligence /marketintelligence/en/news-insights/trending/PbxZH83p6ClvzEAHHN2AYA2 content esgSubNav
In This List

Recordati to buy French over-the-counter drug developer Tonipharm

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Recordati to buy French over-the-counter drug developer Tonipharm

Italy's Recordati Industria Chimica e Farmaceutica SpA will acquire France-based Tonipharm to expand its portfolio of over-the-counter products in the French market.

Tonipharm is expected to generate about €26.5 million in sales in 2018 mainly by a line of products sold under the Ginkor brand.

Financial terms of the deal were not disclosed.

The transaction is expected to close by year-end.